Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Gnathodiaphyseal Dysplasia Gene Mutation

PROVIDER: PRJNA817717 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18360428_1.fastq.gz	Fastqsanger.gz
	SRR18360428_2.fastq.gz	Fastqsanger.gz
	SRR18360429_1.fastq.gz	Fastqsanger.gz
	SRR18360429_2.fastq.gz	Fastqsanger.gz
	SRR18360430_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

miR-140 mutation and skeletal dysplasia

Project description:miR-140 mutation and skeletal dysplasia

| PRJNA384631 | ENA

miR-140 mutation and skeletal dysplasia [seCLIP]

Project description:miR-140 mutation and skeletal dysplasia [seCLIP]

| PRJNA479007 | ENA

Mus musculus

Project description:miR-140 mutation and skeletal dysplasia [SmallRNA-seq]

| PRJNA384642 | ENA

Mus musculus

Project description:miR-140 mutation and skeletal dysplasia [RNA-seq]

| PRJNA384624 | ENA

Expression data from V156D matn1 knock-in mouse rib chondrocytes at 5 days

Project description:V156D matn1 mutation (homologous to the V194D matn3 mutation causing Multiple Epiphyseal Dysplasia (MED)) was introduced by gene targetting in order to evaluate the potential of matrilin-1 to be a novel chondrodysplasia based on domain homology and aminoacid conservation. We used microarrays to analyse the differential expression of genes between wild type and mutant animals at day 5 (postnatal)

2016-05-26 | GSE81880 | GEO

Changes in gene expression in human skeletal stem cells transduced with constitutively active Gsα correlates with hallmark histopathological changes seen in fibrous dysplastic bone

Project description:In order to dissect pathways enchained in skeletal stem/progenitors by Fibrous Dysplasia mutations, we engineered human skeletal stem/progenitors with the mutation and performed transcriptomic analysis. FD mutation profoundly alters the properties of skeletal stem/progenitors by pushing hBMSCs towards formation of disorganized bone with a concomitant lack of fat development. In addition, the mutation created an altered in trans environment that pushed the overall system towards neovascularization, inflammation and osteoclastogenesis. We used microarrays to detail the global programme of gene expressionc of human skeletal progenitors containing the Gsα activating mutation R201C

2018-07-01 | GSE109818 | GEO

Clinical validation study of RAKSET-B, a multiple detection kit for BRAF and RAS gene mutations in colorectal cancer

Project description:Primary outcome(s): BRAF gene mutation* - Overall concordance rate, positive concordance rate, and negative concordance rate of BRAF gene mutations between standard genetic testing such as sanger sequencing and RASKET-B kit RAS gene mutation** - Overall concordance rate, positive concordance rate, and negative concordance rate of RAS gene mutations between MEBGEN RASKET KIT (an established in vitro diagnostic (IVD) kit for detecting RAS mutations) and RASKET-B kit *BRAF gene mutation codon 600 (p.V600E) **RAS gene mutation codon 12, 13, 59, 61, 117, 146

| 2637999 | ecrin-mdr-crc

Gene expressing profiling of PC12 cells expressing the FGFR3 mutation responsible for thanatophoric dysplasia type II

Project description:To investigate signaling pathways activated by FGFR3 mutations through an analysis of altered expression of downstream transcriptional targets, we performed gene expression profiling of stably transfected inducible PC12 cells expressing a chimeric receptor (PFR3) consisting of the extracellular domain of human platelet derived growth factor receptor (PDGFR) and the transmembrane and intracellular domains of human FGFR3 under the control of the zinc inducible metalliothionein promoter. Cells expressing the wildtype receptor (i.e. zinc induced) were compared to cells expressing the mutant receptor PFR3K650E, which contains the thanatophoric dysplasia type II mutation, K650E. See PubMed ID for further description of samples. Keywords = thanatophoric dysplasia Keywords = FGFR3 Keywords = PC12 Keywords = ERK1/2 Keywords: repeat sample

2005-05-06 | GSE2606 | GEO

Mesomelic Dysplasias Associated With The HOXD Locus Are Caused By Regulatory Reallocations [ChIP-Seq]

Project description:Some human families display severe shortening and bending of the radius and ulna, a condition referred to as mesomelic dysplasia. Many of these families contain chromosomal rearrangements at 2q31, where the human HOXD locus maps. In mice, the dominant X-ray-induced Ulnaless inversion of the HoxD gene cluster produces a similar phenotype suggesting that the same pathological mechanism is at work in humans and mice. A tentative hypothesis was proposed where the various alterations to the genomic structure of HOXD could translocate Hoxd13 near to proximal limb enhancers, leading to its deleterious gain-of-expression in the embryonic forelimb. We evaluated this hypothesis by engineering a ca. 1Mb large inversion including the HoxD gene cluster, in order to position Hoxd13 within a chromatin domain rich in proximal limb enhancers. We show that these enhancers contact and activate Hoxd13 in proximal cells, concomitant to the formation of a mesomelic dysplasia phenotype. A secondary mutation in the coding frame of the HOXD13 protein in-cis with the inversion completely rescued the limb alterations, demonstrating that ectopic HOXD13 is indeed the unique cause of this bone anomaly. Single cell expression analysis and evaluation of HOXD13 binding sites in cells from this ectopic expression domain suggests that the phenotype arises primarily by acting through genes normally controlled by HOXD13 in distal limb cells. Altogether, these results provide a conceptual and mechanistic framework to understand and unify the molecular origins of human mesomelic dysplasia associated with 2q31.

2021-07-20 | GSE165761 | GEO

Mesomelic Dysplasias Associated With The HOXD Locus Are Caused By Regulatory Reallocations [CUT&RUN]

2021-07-20 | GSE165492 | GEO